Amicus Therapeutics Inc (NASDAQ:FOLD)

16.36
Delayed Data
As of Jun 15
 -0.05 / -0.30%
Today’s Change
8.50
Today|||52-Week Range
17.40
+13.69%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues1.2M0.005.0M36.9M
 
 
 
 
Cost of Goods Sold--0.00833.0K6.2M
 
 
 
Depreciation And Amortization1.5M1.8M3.2M3.6M
 
 
 
 
 
 
Operating ExpensesGross Income---1.8M883.0K27.1M
 
 
 
 
General Expenses68.3M121.1M169.4M229.5M
 
 
 
 
 
Research And Development47.6M76.9M98.3M141.2M
 
 
 
 
 
Total Operating Expenses69.9M122.9M173.5M239.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-68.7M-122.9M-168.6M-202.4M
 
 
 
 
 
Extraordinary Credit63.0K0.000.00234.3M
 
 
 
Extraordinary Charge-100.0K-8.4M-26.9M-474.2M
 
 
 
 
 
Interest Expense On Debt1.5M1.6M5.4M17.2M
 
 
 
 
 
Other Expenses-77.0K-80.0K-4.5M6.3M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-70.0M-132.1M-203.8M-449.1M
 
 
 
 
 
Income Taxes-1.1M0.00-3.7M-165.1M
 
 
 
 
Net Income-68.9M-132.1M-200.0M-284.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS74.4M109.9M134.4M153.4M
 
 
 
 
 
Shares To Calculate EPS Diluted74.4M109.9M134.4M153.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.93-$1.20-$1.49-$1.85
 
 
 
 
 
EPS Diluted-$0.93-$1.20-$1.49-$1.85